Pulmonary Embolism–Related Mortality in Patients With Cancer
This cohort study found that despite decreases in cancer-related mortality rates, age-adjusted PE-related mortality in US patients with cancer increased over the last decade; concerning trends included rising PE-related mortality in younger individuals aged 15 to 64 years, particular ethnic and racial groups, and the Southern region of the US. Recognition of such patterns may inform further research into thromboprophylaxis and treatment of PE as a complication of cancer and cancer-directed therapy.
Authors
- Anju Nohria
- Stanislav Henkin (ORCID: https://orcid.org/0000-0001-5968-1216)
- Gregory Piazza (ORCID: https://orcid.org/0000-0003-1407-5276)
- Alyssa Sato (ORCID: https://orcid.org/0009-0004-3979-9929)
- Marco Zuin (ORCID: https://orcid.org/0000-0002-4559-1292)
- Darsiya Krishnathasan (ORCID: https://orcid.org/0000-0002-5405-2733)
Institutions
- Brigham and Women's Hospital (US)
- Mayo Clinic (US)
- Harvard University (US)
- University of Padua (IT)
- University of Ferrara (IT)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.60315
- Citations
- 14
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 26.18
Funders
- Amgen
- Bristol-Myers Squibb
- Pfizer
- Alexion Pharmaceuticals